aTyr Pharma
ATYR • NASDAQ
aTyr Pharma is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Sanjay S. Shukla, with a market cap of $73.7M.
CEOSanjay S. Shukla
Next Earnings
Upcoming earnings announcement for aTyr Pharma
Date
Wednesday, May 6, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.15
Revenue Estimate
$20.0K
Earnings History
Past 12 earnings reports for aTyr Pharma
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 5, 2026 | Q4 2025 | -$0.14Est: -$0.18 | +22.2% | -Est: $20.0K | -100.0% |  10-K |
| Nov 6, 2025 | Q3 2025 | -$0.26Est: -$0.19 | -36.8% | -Est: $4.8M | -100.0% | 10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.22Est: -$0.18 | -22.2% | - | — | 10-Q |
| May 7, 2025 | Q1 2025 | -$0.17Est: -$0.19 | +10.5% | - | — | 10-Q |
| Mar 13, 2025 | Q4 2024 | -$0.18Est: -$0.23 | +21.7% | - | — | 10-K |
| Nov 7, 2024 | Q3 2024 | -$0.23Est: -$0.22 | -4.5% | -Est: $20.0K | -100.0% | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$0.23Est: -$0.25 | +8.0% | - | — | 10-Q |
| May 2, 2024 | Q1 2024 | -$0.23Est: -$0.24 | +4.2% | $235.0KEst: $20.0K | +1075.0% | 10-Q |
| Mar 14, 2024 | Q4 2023 | -$0.25Est: -$0.24 | -4.2% | -Est: $50.0K | -100.0% | 10-K |
| Nov 9, 2023 | Q3 2023 | -$0.20Est: -$0.23 | +13.0% | $353.0KEst: $1.5M | -76.5% | — |
| Aug 9, 2023 | Q2 2023 | -$0.22Est: -$0.28 | +21.4% | -Est: $520.0K | -100.0% | 10-Q |
| May 9, 2023 | Q1 2023 | -$0.29Est: -$0.40 | +27.5% | -Est: $300.0K | -100.0% | — |